您好,欢迎访问山西省农业科学院 机构知识库!

Chemical and preclinical studies on Hedyotis diffusa with anticancer potential

文献类型: 外文期刊

作者: Niu, Yu 1 ; Meng, Qiu-Xia 2 ;

作者机构: 1.Shanxi Acad Agr Sci, Inst Agr Resources & Econ, Taiyuan 030006, Peoples R China

2.Shanxi Acad Agr Sci, Inst Agr Environm & Resources, Taiyuan 030006, Peoples R China

关键词: Cancer;Constituents;Hedyotis diffusa;Preclinical;Rubiaceae

期刊名称:JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH ( 影响因子:1.569; 五年影响因子:1.598 )

ISSN:

年卷期:

页码:

收录情况: SCI

摘要: This paper presents the chemical and preclinical anticancer research on Hedyotis diffusa Willd. in detail, one of the most renowned herbs often prescribed in the polyherbal formulas for cancer treatment in traditional Chinese medicine. Anthraquinones, flavonoids, and terpenoids constitute the majority of the 69 compounds that have been isolated and identified from H. diffusa. The anticancer effects of the methanolic, ethanolic, and aqueous extracts in various preclinical cancer models have been described. This review also summarized the anticancer activity of constituents of the herb and the mechanisms of action. All the studies suggest that H. diffusa has enormous potential in the therapy of cancer and warrants further chemical and pharmacological investigation.

  • 相关文献

[1]Ethnopharmacological and bioactivity guided investigation of five TCM anticancer herbs. Meng, Qiu-xia,Roubin, Rebecca H.,Hanrahan, Jane R.,Meng, Qiu-xia. 2013

作者其他论文 更多>>